FDA, FTC send message to biologics makers at competition workshop

10-03-2020

Rory O'Neill

FDA, FTC send message to biologics makers at competition workshop

Jarretera / Shutterstock.com

US drug and antitrust regulators have signalled their intent to crack down on anti-competitive behaviour in the biologics and biosimilar industries, in an effort to bring down prices.


FDA, FTC, US Food and Drug Administration, Stephen Han, Federal Trade Commission, Joe Simons, biologics, biosimilars, antitrust

LSIPR